| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.59B | 89.03B | 77.81B | 71.83B | 69.64B | 56.49B |
| Gross Profit | 8.52B | 8.28B | 5.65B | 5.38B | 6.05B | 5.46B |
| EBITDA | 4.31B | 4.23B | 2.23B | 2.06B | 2.83B | 2.52B |
| Net Income | 2.18B | 2.06B | 1.24B | 1.32B | 1.82B | 1.60B |
Balance Sheet | ||||||
| Total Assets | 56.68B | 55.59B | 59.11B | 45.63B | 48.66B | 40.53B |
| Cash, Cash Equivalents and Short-Term Investments | 4.52B | 4.46B | 8.78B | 10.19B | 7.52B | 6.22B |
| Total Debt | 10.12B | 3.20B | 4.67B | 202.00M | 378.00M | 490.00M |
| Total Liabilities | 33.76B | 32.60B | 36.56B | 24.09B | 28.03B | 21.42B |
| Stockholders Equity | 22.92B | 22.99B | 22.55B | 21.54B | 20.63B | 19.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.71B | -2.65B | 3.53B | 1.85B | -3.23B |
| Operating Cash Flow | 0.00 | -3.06B | -1.92B | 4.19B | 1.96B | -3.09B |
| Investing Cash Flow | 0.00 | 808.00M | -2.99B | -516.00M | -122.00M | 7.00M |
| Financing Cash Flow | 0.00 | -2.07B | 3.70B | -1.01B | -535.00M | -706.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥40.46B | 4.48 | ― | 3.01% | -3.23% | 29.03% | |
78 Outperform | ¥6.21B | 11.79 | 2.90% | 4.53% | -19.04% | -48.45% | |
74 Outperform | ¥35.91B | 6.89 | ― | 3.86% | 15.67% | 85.11% | |
69 Neutral | ¥53.09B | 6.54 | ― | 6.02% | 9.77% | 9.83% | |
68 Neutral | ¥53.76B | 6.36 | 6.98% | 7.35% | -6.83% | -22.86% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
59 Neutral | ¥113.76B | 21.79 | 4.48% | 3.30% | -23.02% | -31.71% |